[1]
“GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS: Gilteritinib (XOSPATA ®) in Turkey”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023031, Apr. 2023, doi: 10.4084/MJHID.2023.031.